The DEA Just Placed a Marijuana-Derived Drug In Schedule V

Marijuana Moment
By Kyle JaegerSep 27, 2018, 9:02 am74 pts
The Drug Enforcement Administration (DEA) placed a marijuana-derived drug in Schedule V of the Controlled Substances Act on Thursday. The medication, Epidiolex, contains purified cannabidiol (CBD), a non-psychoactive ingredient in cannabis. It was approved as a treatment option for severe forms of epilepsy by…

Read Article Share
Share Article
- email
- x.com
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

New Jersey Senate President’s Bill Would Overhaul Marijuana Rules 78

Scutari Bill Calls for Unlicensed Cannabis Crackdown, NJ-CRC Changes 78

CBSA seizes 2,723 kg of cannabis at Montreal Marine and Rail Services 77

Vance, RFK And Other Top Trump Admin Officials Attend MAHA Summit Featuring Psychedelics Session 77

Minnesota Hemp Businesses And Senators Say Federal THC Ban Will Hurt The State’s Economy 76

Squarespace Suspends New York Cannabis Brand’s Online Merch Payments 75

Distressed marijuana MSO Ayr Wellness sells off assets in foreclosure sale 75

Maryland Task Force Recommends Legalizing Natural Psychedelics 74

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.